MicroRNA-193a family as potential clinical biomarker and therapeutic agent in advanced Melanoma

Sara Carpi; Beatrice Polini; Leena Ylösmäki; Erkko Ylösmäki; Vincenzo Cerullo; Antonella Romanini; Paola Nieri

MicroRNA-193a family as potential clinical biomarker and therapeutic agent in advanced Melanoma

Sara Carpi, Beatrice Polini, Leena Ylösmäki, Erkko Ylösmäki, Vincenzo Cerullo, Antonella Romanini, Paola Nieri

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	25
Journal	Journal of Translational Medicine
Volume	18
Issue number	Supplement 1
Number of pages	1
ISSN	1479-5876
Publication status	Published - 11 Feb 2020
MoE publication type	Not Eligible
Event	Immunotherapy Bridge 2019 - Naples, Italy Duration: 4 Dec 2019 → 5 Dec 2019

Access to Document

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011210/

Cite this

@article{4a31f20056584750830e61886f87e5ae,

title = "MicroRNA-193a family as potential clinical biomarker and therapeutic agent in advanced Melanoma",

author = "Sara Carpi and Beatrice Polini and Leena Yl{\"o}sm{\"a}ki and Erkko Yl{\"o}sm{\"a}ki and Vincenzo Cerullo and Antonella Romanini and Paola Nieri",

year = "2020",

month = feb,

day = "11",

language = "English",

volume = "18",

journal = "Journal of Translational Medicine",

issn = "1479-5876",

publisher = "BMC",

number = "Supplement 1",

note = "Immunotherapy Bridge 2019 ; Conference date: 04-12-2019 Through 05-12-2019",

}

TY - JOUR

T1 - MicroRNA-193a family as potential clinical biomarker and therapeutic agent in advanced Melanoma

AU - Carpi, Sara

AU - Polini, Beatrice

AU - Ylösmäki, Leena

AU - Ylösmäki, Erkko

AU - Cerullo, Vincenzo

AU - Romanini, Antonella

AU - Nieri, Paola

PY - 2020/2/11

Y1 - 2020/2/11

M3 - Meeting Abstract

VL - 18

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

IS - Supplement 1

M1 - 25

T2 - Immunotherapy Bridge 2019

Y2 - 4 December 2019 through 5 December 2019

ER -